Read article – Features a brief interview with Saeed Hassanpour, assistant professor of biomedical data science and of epidemiology, in which he discusses how he and fellow Dartmouth colleagues developed a deep learning model that can classify lung cancer subtypes, and could help pathologists achieve quicker, more accurate diagnoses. “We are planning to test our deep learning model in a clinical setting to validate its ability to improve the diagnoses of pathologists. In addition, we are currently applying our method to other histopathology image analysis tasks such as esophageal and colorectal cancer classification,” says Hassanpour. (Similar coverage in Gephardt Daily.)

Read article – Quotes Saeed Hassanpour, assistant professor of biomedical data science and of epidemiology, who worked with colleagues to develop a learning model that can classify lung cancer subtypes, and could help pathologists achieve quicker, more accurate diagnoses. (Similar coverage in Genetic Engineering & Biotechnology News and Health Data Management.)

Read article – Cites a study conducted by researchers at Dartmouth that found that from 1997 through 2016, medical marketing in the U.S. grew from $17.7 to $29.9 billion, with direct-to-consumer advertising for Rx drugs and health services accounting for the most rapid growth.

Read article – Quotes Megan Romano, assistant professor of epidemiology, in an article about how new research is being conducted in New Hampshire on the effects of per- and polyfluoroalkyl substances on pregnant women and young children. Romano is working with the New Hampshire Birth Cohort to get data for 1,000 women from the Concord and Lebanon regions. She hopes to find out more about PFAS exposure’s effects on gestational weight gain, breastfeeding, and early life physical growth of children.

Read article – Quotes Saeed Hassanpour, assistant professor of biomedical data science and of epidemiology, who worked with colleagues to develop a new machine learning model that allows physicians to determine whether atypical ductal hyperplasia (ADH) could upgrade to cancer.

Read article – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, in an article about how to determine whether a screening test you’re considering is needed.  “It only makes sense to get screened if you’re testing for something you can do something about—and if treatment is more effective when the problem is detected before symptoms develop,” says Woloshin.

Read article – Quotes Saeed Hassanpour, assistant professor of biomedical data science and of epidemiology, who worked with colleagues to develop a new machine learning model that allows physicians to determine whether atypical ductal hyperplasia (ADH) could upgrade to cancer.

Read article – A panel of health policy experts examining major proposals to expand Medicare or Medicaid includes Ellen Meara, professor of The Dartmouth Institute for Health Policy and Clinical Practice and adjunct professor in economics. “Expanding coverage to a subset of the population, for example those nearer retirement age, will be cheaper and more politically palatable,” says Meara. “The desire for incremental approaches led us to create Medicare, Medicaid and the Children’s Health Insurance Program, each targeted to specific subgroups of the population.”